======= SRSF3 ======= == Gene Information == * **Official Symbol**: SRSF3 * **Official Name**: serine and arginine rich splicing factor 3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=6428|6428]] * **UniProt**: [[https://www.uniprot.org/uniprot/P84103|P84103]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SRSF3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SRSF3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603364|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Splicing factor that specifically promotes exon- inclusion during alternative splicing (PubMed:26876937). Interaction with YTHDC1, a RNA-binding protein that recognizes and binds N6-methyladenosine (m6A)-containing RNAs, promotes recruitment of SRSF3 to its mRNA-binding elements adjacent to m6A sites, leading to exon-inclusion during alternative splicing (PubMed:26876937). Also functions as export adapter involved in mRNA nuclear export such as of histone H2A (PubMed:11336712, PubMed:18364396). Binds mRNA which is thought to be transferred to the NXF1-NXT1 heterodimer for export (TAP/NXF1 pathway); enhances NXF1-NXT1 RNA-binding activity (PubMed:11336712, PubMed:18364396). RNA-binding is semi-sequence specific (PubMed:17036044). {ECO:0000269|PubMed:11336712, ECO:0000269|PubMed:17036044, ECO:0000269|PubMed:18364396, ECO:0000269|PubMed:26876937}. |RRM 1| |sequence-specific mRNA binding| |phospholipase binding| |mRNA cis splicing, via spliceosome| |regulation of alternative mRNA splicing, via spliceosome| |mRNA 3-end processing| |response to leukemia inhibitory factor| |cellular response to leukemia inhibitory factor| |regulation of mRNA splicing, via spliceosome| |mRNA-containing ribonucleoprotein complex export from nucleus| |mRNA export from nucleus| |ribonucleoprotein complex export from nucleus| |ribonucleoprotein complex localization| |RNA export from nucleus| |RNA 3-end processing| |regulation of RNA splicing| |regulation of mRNA processing| |protein export from nucleus| |mRNA transport| |nuclear export| |RNA transport| |nucleic acid transport| |establishment of RNA localization| |RNA localization| |nucleobase-containing compound transport| |protein-containing complex localization| |nucleocytoplasmic transport| |nuclear transport| |mRNA splicing, via spliceosome| |RNA splicing, via transesterification reactions with bulged adenosine as nucleophile| |RNA splicing, via transesterification reactions| |regulation of mRNA metabolic process| |RNA splicing| |nuclear speck| |mRNA processing| |mRNA metabolic process| |RNA processing| |intracellular protein transport| |cellular response to cytokine stimulus| |response to cytokine| |RNA binding| |protein transport| |intracellular transport| |peptide transport| |amide transport| |cellular protein localization| |cellular macromolecule localization| |establishment of protein localization| |RNA metabolic process| |establishment of localization in cell| |nitrogen compound transport| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp474|CR131-b 0.005μM R08 exp474]]|-2.07| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|-2.01| |[[:results:exp447|Amiloride 100μM R08 exp447]]|-1.96| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|-1.95| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|-1.88| |[[:results:exp355|Dinaciclib 0.007μM R07 exp355]]|-1.81| |[[:results:exp211|AICAR 240μM R05 exp211]]|-1.73| |[[:results:exp69|Deguelin 0.05μM R02 exp69]]|1.72| |[[:results:exp358|FK-506 5μM R07 exp358]]|1.72| |[[:results:exp232|Epothilone-D 0.004 to 0.006μM on day4 R05 exp232]]|1.75| |[[:results:exp136|MS094 2μM R03 exp136]]|1.75| |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|1.8| |[[:results:exp183|IU1-C 25μM R04 exp183]]|1.88| |[[:results:exp145|PNU96415E 10μM R03 exp145]]|1.96| |[[:results:exp123|GSK-LSD1 10μM R03 exp123]]|2.02| |[[:results:exp107|UMK57 0.6μM R03 exp107]]|2.07| |[[:results:exp187|proTAME 5μM R04 exp187]]|2.09| |[[:results:exp437|Ethanol 0.003 R08 exp437]]|2.22| ^Gene^Correlation^ |[[:human genes:p:psmb4|PSMB4]]|0.485| |[[:human genes:v:vps28|VPS28]]|0.405| Global Fraction of Cell Lines Where Essential: 717/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|28/28| |blood|28/28| |bone|24/25| |breast|31/33| |central nervous system|56/56| |cervix|4/4| |colorectal|15/17| |esophagus|13/13| |fibroblast|1/1| |gastric|15/15| |kidney|21/21| |liver|20/20| |lung|75/75| |lymphocyte|14/14| |ovary|26/26| |pancreas|24/24| |peripheral nervous system|16/16| |plasma cell|15/15| |prostate|1/1| |skin|24/24| |soft tissue|7/7| |thyroid|1/2| |upper aerodigestive|22/22| |urinary tract|29/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1393 * **Expression level (log2 read counts)**: 9.02 {{:chemogenomics:nalm6 dist.png?nolink |}}